The purpose of this proposal is to extend our studies on the mechanism of action, at the biochemical and genetic levels, of tumor promoters. Based on a stereochemical model of tumor promoter-receptor binding several types of compounds will be synthesized and tested for in vitro activities characteristic of known tumor promoters and for possible anti-promoter activity. Fluorescent and photoaffinity derivatives of phorbol esters will also be prepared and used for mechanistic studies. The enzyme protein kinase C, (PKC), a putative site of action of phorbol ester tumor promoters and related compounds, will be purified to homogeneity, antibodies prepared and the PKC gene(s) cloned by recombinant DNA techniques. This will permit a direct analysis of the role of this enzyme in tumor promotion. We will also explore the possibility that certain types of tumor promoters produce direct effects on mitochondria and/or directly active membrane-associated phospholipases. Defined amphiphilic polypeptides will be utilized in several of these studies to determine if they mimic or antagonize the action of known tumor promoters. Finally, we will study the possibility that tumor promoters can act synergistically with cellular oncogenes and/or activate LTR-like DNA sequences during multistage carcinogenesis. Hopefully, these studies will provide a more rational basis for detecting potential tumor promoters in the environment and lead to new strategies of cancer prevention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA026056-08
Application #
3167168
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1979-12-01
Project End
1989-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
8
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Li, Haiyang; Weinstein, I Bernard (2006) Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Cancer Res 66:11399-408
Li, H; Zhang, Y; Su, T et al. (2006) Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 25:713-21
Soh, Jae-Won; Weinstein, I Bernard (2003) Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 278:34709-16
Soh, Jae-Won; Weinstein, I Bernard (2003) Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog Exp Tumor Res 37:261-85
Soh, Jae-Won; Lee, Yun-Sil; Weinstein, I Bernard (2003) Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells. J Exp Ther Oncol 3:115-26
Page, Kristen; Li, Jing; Zhou, Limei et al. (2003) Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta. J Immunol 170:5681-9
Page, Kristen; Li, Jing; Corbit, Kevin C et al. (2002) Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta. Am J Respir Cell Mol Biol 27:204-13
Corbit, K C; Soh, J W; Yoshida, K et al. (2000) Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol 20:5392-403
Chiang, S Y; Burli, R W; Benz, C C et al. (2000) Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides. J Biol Chem 275:24246-54
Soh, J W; Lee, E H; Prywes, R et al. (1999) Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19:1313-24

Showing the most recent 10 out of 24 publications